Given the challenges public sector organisations face with excessive paperwork, Intelligent Document Processing (IDP) offers a solution to enhance efficiency by automating document capture, extraction, classification, and decision-making.
Ann G. Matthysse, from the University of North Carolina’s Department of Biology, delves into an exploration of harmful and useful bacteria for elementary school students.
David Turner, Managing Director of MSC Digital, outlines the key features of technology design to ensure your organisation can support a complete or partial remote-first workforce.
Jack Williams, Strategic Product Manager – AI & Analytics, Hexagon’s Safety & Infrastructure division, explores how assistive artificial intelligence (AI) will help public safety and smart cities of the future.
Dr Janet Young, Government Chief Property Officer for the UK government and a Director General in the Cabinet Office, explains why property is seen as an enabler to kick-start local economic growth.
Suzanne Gallagher, Associate, BCL Solicitors LLP, explains the current legal position in the balance between human rights, privacy and the use of biometric technology by the police and other groups.
Enzo Brienza, sales manager, InterSystems, discusses why higher education institutions need to consider collaboration with other organisations to generate value from research data.
In this article, tech experts explore the core components of data governance and protection in today’s cyber business landscape and offer advice on how an organisation must act if a data breach occurs.
New mathematical modelling from the University of Utah suggests that all severe COVID infections will disappear over the next ten years - if the global population has access to vaccination.
Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
